ImmuPharma PLC

www.immupharma.com Financials
  • Watchlist/Portfolio

    Add to watchlist:

    Only registered members can add into watchlist !

    Register here !
Overview
Financials (in $m unless stated)
Sales 0.017
EBITDA -
Operating Profit -3.836
Pre-tax Profit -3.613
Net Profit -3.355
Capex -
Operating Cash Flow -3.367
Net Working Capital -
Key Ratios
EBITDA Margin -
Operating Profit Margin -22,564.7%
Net Profit Margin -19,735.3%
Capex/Sales (%) -
NWC/Sales (%) 737.8x
Asset Turnover 0.0x
Days Inventory - days
Days Receivable -
Days Payable -
Performance (Last 3 Years)
Sales CAGR -
EBITDA CAGR -
Operating Profit CAGR -
Profit CAGR -
Return on Equity
Return on Assets -
Return on Invested Capital (ROIC) -
ROIC - WACC -
Valuation
Market Cap 51.47 m
Price to Earnings 10.17
Price to Book Value -
Price to Tangible Book -
Equity to FCF Yield -
Enterprise Value 41.079
EV to Sales -
EV to EBITDA -
EV to Operating Profit -
EV to Invested Capital -
EV to FCF Yield -
Dividend Yield 0.00
Payout Ratio 0.00
Per Share Data (in GBp unless stated)
Earnings per share (31/12/11) -4.12
Operating Cashflow per share -
Free Cashflow per share -
Dividend per share 0.00
NAV per share -
Cash per share -
Solvency
Intangibles Incl. Excl.
Net debt to Equity % -72.8% -
Cash to Equity % 1.0x -
Gross debt to Equity % 12.4% -
Gross Debt < 1 Year to Equity - -
Net debt to Assets % 6.2x
Net Debt/EBITDA - -
Net Interest Cover - -
Op Cashflow Interest Cover - -
Current Ratio 14.2579281184 -
Quick Ratio 14.2579281184 -
Cash Ratio 12.8594080338 -
Dividend Cover 0.00 -
Key Dates
Latest Dividend Pay date -
Latest Ex-Dividend date -
Last Annual Results 31/12/11
Last Interim Results 30/06/11